ENTRY       D00783                      Drug
NAME        Botulinum toxin type A (JAN);
            Botox (TN);
            Dysport (TN)
PRODUCT     DAXXIFY (Revance Therapeutics)
            DYSPORT (Galderma Laboratories)
            DYSPORT (Ipsen Biopharmaceuticals)
SOURCE      Clostridium botulinum A [TAX:36826]
CLASS       Musculo-skeletal system agent
             DG02029  Muscle relaxant
              DG01696  Peripherally-acting muscle relaxant
               DG03117  Nondepolarizing neuromuscular blocking agent
REMARK      Same as: C07946
            Therapeutic category: 1229 2590
            ATC code: M03AX01
            Chemical structure group: DG00772
            Product (DG00772): D00783<JP/US> D02735<JP/US> D11405<US>
EFFICACY    Skeletal muscle relaxant, Neuromuscular blocking agent
  DISEASE   Cervical dystonia [DS:H01608]
TARGET      SNAP25 [HSA:6616] [KO:K18211]
  PATHWAY   hsa04721(6616)  Synaptic vesicle cycle
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M03 MUSCLE RELAXANTS
               M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
                M03AX Other muscle relaxants, peripherally acting agents
                 M03AX01 Botulinum toxin
                  D00783  Botulinum toxin type A (JAN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               122  Skeletal muscle relaxants
                1229  Others
                 D00783  Botulinum toxin type A (JAN)
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               259  Miscellaneous
                2590  Miscellaneous
                 D00783  Botulinum toxin type A (JAN)
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG02029  Muscle relaxant
               DG01696  Peripherally-acting muscle relaxant
                DG03117  Nondepolarizing neuromuscular blocking agent
                 DG00772  Botulinum toxin
                  D00783  Botulinum toxin type A
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Nervous system
                SNAP25
                 D00783  Botulinum toxin type A (JAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00783
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG02029  Muscle relaxant
               DG01696  Peripherally-acting muscle relaxant
                DG03117  Nondepolarizing neuromuscular blocking agent
                 DG00772  Botulinum toxin
DBLINKS     CAS: 93384-43-1
            PubChem: 7847848
            ChEBI: 3160
///
